Depression Moderate
23
11
13
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
1 terminated out of 23 trials
88.9%
+2.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (23)
fMRI Neurofeedback With Matter Neuroscience App
Paramedical Tele-education on Moderate Depressive Episodes
Exercise Recovery From Persistent Depression: A Thematic Analysis
Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2
Treating Major Depression With Yoga Mono-therapy
Telehealth Behavioral Activation for Teens
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression
Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment
Kintsugi Voice Device Pivotal Study
iCBT for Seniors With Depression in Primary Care
Kintsugi Voice Device Pilot Study
The Cerebral and Cognitive Changes After Intermittent Theta Burst Stimulation (iTBS) Treatment for Depression
Evaluation of DEPREXIL in Patients With Clinical Depression Through Psychological and Neuroendocrine Assessment
A Pilot Study Comparing the Efficacy of Traditional Buddhist Mindfulness Training Versus Secular Mindfulness-based Cognitive Therapy for Patients Having Residual Depressive Symptoms
Integrated Depression Care
Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression (OASIS-D)
Long-term Effects ReSet Your Mind - Mechanisms
An Online Intervention Targeting Depression and Low Reward Sensitivity
Treatment of Depression Using a Mobile Application in the Dominican Republic
Real-time fMRI Neurofeedback for Mild/Moderate Depression